A quick note for international readers: this is Caledonian Holdings on London's AIM market. The shares are quoted in pence, so the current price is approximately 1.65p, not £1.65. There is no US ADR, and the shares won't be available through Robinhood or many American brokers.
Disclosure: I own circa 35,000 shares. This is a speculative microcap position, and I'm sharing the research to see what others make of it.
The setup
Caledonian Holdings has recently transformed from a passive investment company into a small financial-services group. At the current share price, the entire company is valued at approximately £2.1m — and for that price, CHP now offers exposure to two potentially significant businesses: AlbaCo, which is working towards becoming a UK bank, and Aspire Commerce Group, an operating payments, FX and trade-finance business.
That's the pitch in one line: a sub-£2.1m market cap sitting on top of a bank-in-progress and a live payments operation. The rest of this note is about why I think that combination is more interesting than the price implies, and what would need to go right for the market to agree.
AlbaCo: further along than it looks
CHP currently states that it owns 5.47% of AlbaCo. It has also advanced approximately £2.31m in funding and could receive additional fees and warrants if the transaction completes.
AlbaCo has received conditional approval from the PRA and FCA to become a UK deposit-taking bank. The outstanding requirements are securing £25m of regulatory capital and completing the remaining regulatory steps — and in March 2026, AlbaCo announced that a £25m regulatory-capital subscription agreement had already been signed. Subject to conditions being satisfied and the funds being drawn, AlbaCo intends to proceed towards unconditional authorisation and launch.
AlbaCo isn't a fully licensed operating bank yet, but it's considerably further through the process than a typical early-stage fintech applying from scratch. It previously received authorisation with restrictions under the name Alba Bank and entered the mobilisation stage. That earlier process wasn't completed, and the Bank of England currently lists Alba Bank as no longer PRA-authorised, so the current conditional approval and capital agreement represent a renewed route to launch rather than a continuation of a live licence. To me, that history is actually informative in a good way: it shows the regulatory groundwork has already been built once, by a team that knows what the PRA and FCA expect.
Why the Revolut timeline is a useful reference point
I'm not suggesting AlbaCo is comparable with Revolut in customers, revenue or valuation — Revolut operates on a completely different scale. But the regulatory timeline is a useful reference point. Revolut applied for its UK banking licence in 2021, received authorisation with restrictions in July 2024, and only launched its UK bank in March 2026 — nearly five years from application to launch, for one of Europe's largest and best-funded fintechs.
That's the point worth taking from the comparison: UK banking authorisation is slow and expensive for everyone, which means genuine regulatory progress is hard to replicate quickly or cheaply. CHP's market cap currently appears to assign relatively little value to holding a stake this far along that path. The open question — and the one that will matter most to what this is ultimately worth — is what percentage CHP retains once AlbaCo completes the £25m capital raise.
Aspire: a real operating business, not just an option
Alongside AlbaCo, CHP acquired Aspire Commerce Group for a nominal £1, alongside the restructuring of approximately £9.33m of existing debt. Aspire operates across payments, foreign exchange and trade finance, and its payments subsidiary is authorised by the FCA as a Small Electronic Money Institution (not a banking licence, but a real regulatory permission with customers transacting under it today).
As of May 2026, Aspire reported:
- 128 live customers
- More than 7,300 transactions
- Payment flows of £57.3m, €24.3m and $1.3m
- Approximately £1m of live trade-finance facilities
- A £12.5m active trade-finance pipeline
- Access to an initial additional funding line of up to £30m
That's meaningfully more than a shell with an idea — there are live customers, real transaction volumes, and a funding line already in place. The task for management now is converting that activity into recurring revenue. Aspire's unaudited 2025 figures are still early-stage (revenue of approximately £124,000 and a pre-tax loss of £3.58m — typical for a business at this point in its build-out), and transaction volumes and pipeline shouldn't be mistaken for revenue — but they do show genuine operating activity for management to build on. Just as importantly, Aspire means CHP is no longer a single-bet story dependent entirely on AlbaCo.
What might the market be missing?
At approximately £2.1m, CHP is valued below the amount it has advanced to AlbaCo alone. That doesn't automatically mean the shares are undervalued — AlbaCo remains private, conditional and genuinely hard to value — but it does suggest the market is pricing in a lot of scepticism: that AlbaCo won't complete authorisation, that CHP's eventual stake will be heavily diluted, or that Aspire won't convert its activity into profitable revenue.
Neither AlbaCo nor Aspire needs to become the next Revolut for that view to be too pessimistic. At CHP's size, progress that would barely move the needle for a large financial group could still be material to its shareholders. If AlbaCo completes authorisation and CHP retains a meaningful interest, or if Aspire starts reporting material revenue from its payments and trade-finance activity, either one gives the market a reason to revisit the current price.
My view
This isn't a conventional value investment with stable earnings and an easily calculated fair value — it's a financial-services special situation. But the asymmetry is what makes it interesting: a ~£2.1m valuation against a stake in a bank that's already cleared conditional regulatory approval and signed a £25m capital agreement, plus an operating payments and trade-finance business with live customers and a funding line.
The market may ultimately be right to apply a heavy discount for execution and financing risk — that's a reasonable, defensible position. But at the current price, there seems to be limited room priced in for either asset actually making progress, which is why I think CHP is worth following closely from here. It appears to me to have a great probable upside,
I'd be interested to hear how others would value the AlbaCo interest, and what they see as the strongest bear case.
Sources:
